about
Polyplex Nanogel formulations for drug delivery of cytotoxic nucleoside analogs.Non-viral gene delivery using nanoparticles.Polyamine structural effects on the induction and stabilization of liquid crystalline DNA: potential applications to DNA packaging, gene therapy and polyamine therapeutics.Formation of DNA nanoparticles in the presence of novel polyamine analogues: a laser light scattering and atomic force microscopic study.Enhanced cellular uptake of a triplex-forming oligonucleotide by nanoparticle formation in the presence of polypropylenimine dendrimersDNA release dynamics from reducible polyplexes by atomic force microscopy.Investigation on the aggregation behaviors of DDAB/NaDEHP catanionic vesicles in the absence and presence of a negatively charged polyelectrolyte.Dually fluorescent core-shell microgels for ratiometric imaging in live antigen-presenting cellsModular plasmonic nanocarriers for efficient and targeted delivery of cancer-therapeutic siRNA.Structure and biological activity of pathogen-like synthetic nanomedicines.Targeted polymers for gene delivery.Women and heart disease--physiologic regulation of gene delivery and expression: bioreducible polymers and ischemia-inducible gene therapies for the treatment of ischemic heart disease.Cationic nanoparticles for cancer therapy.Self-assembling viral mimetics: one long journey with short steps.Progressive macromolecular self-assembly: from biomimetic chemistry to bio-inspired materials.Supramolecular systems based on novel mono- and dicationic pyrimidinic amphiphiles and oligonucleotides: a self-organization and complexation study.History of Polymeric Gene Delivery Systems.Coarse-graining intermittent intracellular transport: Two- and three-dimensional models.Serum decreases the size of Metafectene-and Genejammer-DNA complexes but does not affect significantly their transfection activity in SCCVII murine squamous cell carcinoma cells.Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).Photochemically enhanced gene delivery of EGF receptor-targeted DNA polyplexes.Combined suicide gene therapy for pancreatic peritoneal carcinomatosis using BGTC liposomes.How to Tackle the Challenge of siRNA Delivery with Sequence-Defined Oligoamino Amides.Optimization of brush-like cationic copolymers for nonviral gene delivery.Dual responsive, stabilized nanoparticles for efficient in vivo plasmid delivery.Loading capacity and interaction of DNA binding on catanionic vesicles with different cationic surfactants.The AGMA1 polyamidoamine mediates the efficient delivery of siRNA.Virus-sized DNA nanoparticles for gene delivery based on micelles of cationic calixarenes.Quantitative analysis of virus and plasmid trafficking in cells.omega-Hydrazino linear polyethylenimine: a monoconjugation building block for nucleic acid delivery.Targeted gene delivery to cancer cells with nanometric DNA particles enveloped with folic acid using a polymerisable anchor.Kanamycin A-derived cationic lipids as vectors for gene transfection.Transduction Methods for Cytosolic Delivery of Proteins and Bioconjugates into Living Cells.Chemo-physical and biological evaluation of poly(L-lysine)-grafted chitosan copolymers used for highly efficient gene delivery.Complex formation between cationic beta-1,3-glucan and hetero-sequence oligodeoxynucleotide and its delivery into macrophage-like cells to induce cytokine secretion.Quantifying intermittent transport in cell cytoplasm.Three-dimensional printed PLA scaffold and human gingival stem cell-derived extracellular vesicles: a new tool for bone defect repair.A novel role in skeletal segment regeneration of extracellular vesicles released from periodontal-ligament stem cells.Chemically modifiable N-heterocycle-functionalized polycarbonates as a platform for diverse smart biomimetic nanomaterials
P2860
Q24540353-CF2E2BF5-B509-4E04-9A69-9654C27698CFQ30381073-781C2F23-C2DB-4BD6-89CF-09689D99B81FQ31106045-9D817659-E51D-419D-A0CB-795964424BB3Q33196404-DB854EB6-7194-4A6A-9DB3-CBD629290C07Q33201676-C8D5F7E5-A3EA-48CB-AD92-C045D1B8586BQ33671439-C20573FF-668D-4896-A1FD-7DFE62539871Q33825123-57336F16-6880-4662-A5F0-651754CD3285Q35088571-E3810A7B-C427-4A69-8B39-AE3D1F6BE686Q35111718-680CAE27-CF68-46A8-8F80-AFCE81BBFD06Q35742894-5E0DE27F-4BC3-4720-A6D6-7C0ACE84C570Q36316688-13CEFA51-7A2C-4C21-82D4-D76FA37CF987Q37284978-E80A28A3-9A46-4594-9036-D199B8BF39CCQ37743515-2F058D82-5B50-4EC9-962D-1A9CB893280AQ37821835-16F18ADC-DB1A-42ED-81B1-4066466010BAQ38136156-0FED56C6-EBF0-4070-B862-B02E7F814901Q38328185-A463444F-C67E-4A8C-B8F4-FBCC7227323FQ38759514-293426C0-633F-4F40-B106-CD30E781CBCDQ38943069-96FA54F8-A715-4549-961F-5E80BE0978C8Q40254555-DDB77E5E-9CA9-4962-BCBC-2B3031901236Q40436528-DBD8DA21-99A3-4780-9730-7EE0FBF7F410Q40499765-AD14B932-52DD-47AA-988E-32FE6925D6CBQ40606264-6258C3BB-C461-4913-8B8D-5C26542C177BQ40689442-EC96831D-0090-401C-BDED-399C9C12F14FQ42237653-9315EB6B-7170-426A-B10E-FAE056F0BAEBQ42546124-84A7C93D-2D76-48A5-A61C-3D440958EECBQ43726473-E0EA9C0D-122A-42E9-8CCD-90DC0545A601Q44134724-98F68296-2C7C-4AAB-8B37-04EBF1D67423Q45367245-9582EC1D-183D-4B25-82E4-200E7AA790ADQ45386231-D00CF0B4-9EE4-4938-9A8F-0336AE75BD61Q45855279-B00C1487-8573-4160-9B0E-27B5101C318FQ45888639-8AE89D4B-C458-48F3-94A2-D7A6F6E9B05BQ46482071-BDE68E07-6C24-41A9-8278-448AB83DD849Q47283251-F32867C6-5822-4A0E-9A33-8B85F4DF6A65Q50530155-F467A2B7-DA6F-4463-AF86-03FD0E52F86CQ50962315-449826B7-E5E6-49BF-84D1-8CC219463A6AQ51621249-01073533-0FC7-455D-8353-5964AE5847CEQ52589505-3FA415D9-2865-42E8-B14E-4DE625F18AB3Q55518085-73BF46D0-E595-45D2-9E8D-DB08C1CEDE59Q56336389-3615656A-BD4C-4535-BBE4-0F62F7020D43
P2860
description
2001 nî lūn-bûn
@nan
2001 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Towards synthetic viruses.
@ast
Towards synthetic viruses.
@en
Towards synthetic viruses.
@nl
type
label
Towards synthetic viruses.
@ast
Towards synthetic viruses.
@en
Towards synthetic viruses.
@nl
prefLabel
Towards synthetic viruses.
@ast
Towards synthetic viruses.
@en
Towards synthetic viruses.
@nl
P2093
P1476
Towards synthetic viruses.
@en
P2093
P304
P356
10.1016/S0169-409X(01)00213-7
P407
P577
2001-11-01T00:00:00Z